GSD and DHGR Related Headlines
Go Back- Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine™ Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients
- Devonian Health Group Provides Update on its Planned NYSE American Listing
- Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American
- Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
- Devonian Health Group plans NYSE American listing and share offering
- Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
GSD and DHGR Related Press Releases
Go Back- Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine™ Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients
- Devonian Health Group Provides Update on its Planned NYSE American Listing
- Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American
- Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
- Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
